✦ LIBER ✦

Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma

✍ Scribed by Westin, Jason R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The PI3K/AKT/MTOR Signaling Pathway: The

✍ Huemer, Florian; Bartsch, Rupert; Gnant, Michael 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 355 KB

227 POSTER Anti-angiogenic effects of PI

✍ L. Friedman; M. Belvin; J. Le Couter; K. Lin; L. Robillard; D. Sampath; H. Stern 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

PI3K/Akt/mTOR pathway inhibitors in the

✍ Wolin, Edward M. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 707 KB

2 Agents Targeting the mTOR-PI3K-Akt Pat

✍ Tabernero, J.; Dienstmann, R.; Macarulla, T.; Saura, C.; Argiles, G.; Alsina, M. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

SP 114 Predictive and pharmacodynamic (P

✍ J. Tabernero 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Defining biomarkers to predict sensitivi

✍ Gonzalez-Angulo, A.M.; Blumenschein, G.R. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 411 KB